Chemoprevention of head and neck cancer with green tea polyphenols

Related Experiment Video

Updated: Jun 10, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

Joseph W Kim1, A R M Ruhul Amin, Dong M Shin

  • 1Emory University, Atlanta, GA 30322, USA. dmshin@emory.edu

Cancer Prevention Research (Philadelphia, Pa.)
|July 29, 2010
PubMed

Insights

Green tea polyphenols, especially EGCG, show promise for preventing head and neck squamous cell carcinoma. EGCG targets key pathways and works well with other compounds.

Area of Science:

  • Oncology
  • Chemoprevention
  • Molecular Biology

Background:

  • Head and neck squamous cell carcinoma (HNSCC) research is advancing with new trial designs and biomarkers.
  • Natural compounds, including green tea polyphenols, are emerging as potential chemopreventive agents for HNSCC.

Purpose of the Study:

  • To review the potential of green tea polyphenols, specifically (-)-epigallocatechin-3-gallate (EGCG), for HNSCC chemoprevention.
  • To update on recent advances in HNSCC chemoprevention research.

Main Methods:

  • Literature review focusing on EGCG's molecular mechanisms and clinical applications.
  • Analysis of EGCG's effects on key molecular signaling pathways relevant to HNSCC.

Main Results:

  • EGCG demonstrates significant potential as a chemopreventive agent for HNSCC.
  • EGCG modulates multiple molecular signaling pathways involved in cancer development.
  • EGCG exhibits synergistic or additive effects when combined with other therapeutic agents.

Conclusions:

  • Green tea polyphenols, particularly EGCG, represent a promising strategy for HNSCC chemoprevention.
  • EGCG's multifaceted action on molecular pathways supports its role in cancer prevention.
  • Further research and clinical trials are warranted to fully establish EGCG's efficacy in HNSCC prevention.

More Related Videos

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...